Background & Aims: In view of the mortality and morbidity rates of esophagectomy and the
relatively large group of inoperable patients, local therapeutic techniques are required for …

BACKGROUND: In view of the increasing incidence of adenocarcinoma in Barrett's
esophagus and the mortality and high morbidity rates associated with surgical therapy for …

OBJECTIVES: Patients with Barrett's high-grade dysplasia (HGD) or early esophageal
adenocarcinoma (EAC) that is shown on biopsy alone continue to undergo esophagectomy …

BACKGROUND: The aim of this study was to prospectively evaluate endoscopic resection
(ER) combined with photodynamic therapy (PDT) for the treatment of selected patients with …

Results: 31 patients had no neoplasia and were excluded from the analysis. Among the
remaining 295 patients (711 resection specimens), histological findings were: low-grade …

AIM: To evaluate endoscopic mucosal resection (EMR) in patients with high-grade dysplasia
(HGD) and/or intramucosal cancer (IMC) in Barrett's esophagus (BE). METHODS: Between …

OBJECTIVES Endoscopic therapy for early neoplasia in Barrett's esophagus (BE) is
evolving rapidly. Aim of this study was to prospectively evaluate safety and efficacy of …

Background Barrett's esophagus–related high-grade dysplasia or mucosal cancer can be
treated by endoscopic mucosal resection (EMR), but the adjacent metaplastic epithelium …

Background: Endoscopic mucosal resection has been used in the treatment of superficial
squamous cell cancers and gastric malignancies. Our aim was to determine whether …

Background. The incidence of Barrett's-associated esophageal adenocarcinoma is rising,
but experience in the treatment of high-grade dysplasia (HGD) or early cancer is limited …